Opinion: Lab Work Under Isolation

Here’s how my group put our research on pause and how we’ve continued our work from home.

Written byKate Adamala, PhD
| 4 min read
the inside of a laboratory freezer

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, TONAQUATIC

My lab focuses on synthetic biology research, specifically, building synthetic cells for studying modern terrestrial life and for investigating the possibilities for life elsewhere in the Solar System. Our work is not directly applicable to detection, prevention, or treatment of viral diseases, so there’s nothing immediately useful for the COVID-19 effort that we could be doing in the lab. Thus, for everyone’s safety our lab has been working remotely since the middle of March as a result of first a campus-wide non-essential operation shutdown order, followed by a state-wide shelter in place order a couple days later.

Not being able to do lab work means we cannot make much progress on any of our experimental projects. This doesn’t mean we cannot get any work done, though. I share our experiences here with the hope that they may be useful to other researchers during the current shutdown, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • <span lang="EN" >Kate Adamala Headshot</span>

    Kate Adamala is McKnight Presidential Fellow Associate Professor at the University of Minnesota. Her research focuses on synthetic cell engineering, with the aim of understanding chemical principles of biology, using artificial cells to create new tools for bioengineering and basic research. Kate is a Polymath Fellow of the Geneva Center for Security Policy, and co-founder and coordinator of the international synthetic cell engineering consortium Build-a-Cell. 

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies